Function Health, a preventive health startup, has closed a $298 million Series B to launch its Medical Intelligence Lab, a generative AI engine trained by clinicians to deliver personalized health insights using lab tests, imaging, wearables, and health records.
Glimpse:
The funding round, led by Redpoint Ventures (with participation from a16z and several celebrity investors), values Function at $2.5 billion. The MI Lab will offer members an AI chatbot to answer health-data-driven questions, upload past medical records, and convert complex biomarker data into comprehensible, actionable health protocols.
Function Health, headquartered in Austin, has raised $298 million in an oversubscribed Series B round, achieving a valuation of $2.5 billion. The investment will primarily fuel the company’s newly formed Medical Intelligence Lab, which seeks to unify diverse health data from lab tests and imaging to wearables and medical records into a continuously learning AI system.
The MI Lab is co-directed by Function’s Chief Medical Scientist Dr. Dan Sodickson and co-founder/CMO Dr. Mark Hyman.Function is building out tools that include:
A private AI chat that answers personal health questions rooted in a user’s data
Protocols that translate biomarker results into practical health-improvement steps
A secure system for users to upload past lab results and doctor’s notes to inform the AI’s guidance.
Function’s long-term mission is to empower individuals to manage their biology proactively: the company aims to make health forecasting and personalized prevention accessible, not reactive.
“AI alone is not enough; our Medical Intelligence Lab combines deep clinical expertise and personal biology to deliver insights that matter helping people truly understand their health trajectory.”
By
HB Team
